News

Market Performance: The Hang Seng Index (HSI) rose by 239 points (0.9%) to close at 26,848, with a total market turnover of $315.19 billion.
Active Heavyweights: Notable stock movements included Alibaba (+3.6%), Ping An (+2.2%), and Tencent (+0.7%), while Xiaomi saw a decline of 2%.
HSI & HSCEI Constituents: Wuxi Apptec surged by 8.3%, and China Life increased by 3.5%, both hitting new highs, while Tingyi dropped by 4.3%.
HSMI & HSSI Constituents: Fangzhou Jianke experienced a significant rise of 65.8%, while Breton fell by 15.6%, reflecting varied performance among smaller stocks.

Market Performance: The NASDAQ Golden Dragon China Index rose over 4%, with Alibaba ADR leading the charge by climbing 10%, contributing to a strong opening for the Hong Kong bourse, which saw the HSI open 350 points higher and close the morning session up 268 points.
Technology Sector Movements: In the technology sector, notable stocks like BABA-W and ALI HEALTH saw gains of 3.5% and 3.3% respectively, while other major players like TENCENT and JD-SW also experienced slight increases, despite some stocks like MEITUAN-W and BIDU-SW declining.
Pharmaceutical Sector Highlights: The 44th JPMorgan Healthcare Conference commenced in San Francisco, with several Chinese pharmaceutical companies participating, leading to significant gains for stocks such as REMEGEN, which surged 11.6%, and CSPC PHARMA, which jumped 5.7% after its innovative drug application was accepted.
AI Concept Stocks Decline: Several AI concept stocks, including SENSETIME-W and WEIMOB INC, experienced declines ranging from 3.3% to 4.2%, while other stocks like KNOWLEDGE ATLAS and MINIMAX-WP saw even steeper drops of 8.8% and 7.5% respectively.

Market Performance: The Hang Seng Index (HSI) rose by 268 points (1.0%) to 26,877, while the Hang Seng Tech Index (HSTI) and the Hang Seng China Enterprises Index (HSCEI) also saw gains of 0.4% and 0.8%, respectively.
Active Heavyweights: Notable stock movements included Alibaba (BABA) up 3.5%, Ping An (02318.HK) up 2%, and Tencent (00700.HK) up 0.5%, while Meituan (03690.HK) and Xiaomi (01810.HK) experienced declines.
Top Gainers: Wuxi Apptec (02359.HK) surged by 7.9%, followed by CSPC Pharma (01093.HK) with a 5.7% increase, and Wuxi Bio (02269.HK) up 4.3%, indicating strong performance among certain constituents.
Short Selling Activity: Significant short selling was observed in several stocks, with Xiaomi and Meituan having high short selling ratios of 31.1% and 12.6%, respectively, reflecting market sentiment and trading strategies.

Top Ten Net Buys: The top net buys of Hong Kong stocks by southbound capital included XIAOMI-W, PING AN, and BABA-W, with significant inflows of HK$3.148 billion, HK$2.881 billion, and HK$2.016 billion respectively.
Top Ten Net Sells: The leading net sells were CHINA MOBILE, SMIC, and CHINAHONGQIAO, with outflows of -HK$2.402 billion, -HK$696 million, and -HK$566 million respectively.
Short Selling Data: The report included short selling data, indicating varying ratios for each stock, with notable short selling amounts for both net buys and sells.
Data Source Note: The data presented is estimated by Soochow Securities based on changes in shareholdings and average transaction prices, rather than being published by the exchange.

NASDAQ Golden Dragon China Index Performance: The NASDAQ Golden Dragon China Index surged over 4%, with Alibaba ADR leading the charge, rising 10%, which positively influenced the opening of Hong Kong stocks.
Hong Kong Stock Market Opening: The Hang Seng Index (HSI) opened 350 points higher at 26,958, while the HSCEI and HSTECH also saw significant increases of 115 points and 113 points, respectively.
Tech Sector Movements: Major tech stocks like Alibaba, Tencent, and Meituan opened higher, with Alibaba-W rising 5% and Tencent increasing by 2.2%, amidst notable short selling activity.
Sector Highlights: In the auto sector, BYD and XPENG saw increases of 4.1% and 3.5%, respectively, while pharmaceutical stocks like WUXI APPTEC projected a significant profit increase, leading to a 4.7% rise in share price.
Forward PE

Forward EV/EBITDA

Forward PS
